Forbion Team
Photo of Philip Astley-Sparke, Venture Partner at Forbion
Philip Astley-Sparke
Forbion·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Juliette Audet, Partner at Forbion
Juliette Audet
Forbion·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Netherlands
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)
Photo of Marco Boorsma, General Partner at Forbion
Marco Boorsma
Forbion·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Naarden (Netherlands), Investors in Amsterdam (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A)
Photo of Jasper Bos, General Partner at Forbion
Jasper Bos
Forbion·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Photo of Antoine Boulanger Piette, Principal at Forbion
Antoine Boulanger Piette
Forbion·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Photo of Audrey Cacaly, Principal at Forbion
Audrey Cacaly
Forbion·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Netherlands
Photo of Dmitrij Hristodorov, General Partner at Forbion
Dmitrij Hristodorov
Forbion·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Munich (Germany)
Photo of Wouter Joustra, General Partner at Forbion
Wouter Joustra
Forbion·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Investors in BioTech (Series B)
Photo of Dirk Kersten, General Partner at Forbion
Dirk Kersten
Forbion·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Photo of Nanna Luneborg, General Partner at Forbion
Nanna Luneborg
Forbion·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Denmark
Photo of Geert-Jan Mulder, Managing Partner at Forbion
Geert-Jan Mulder
Forbion·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Naarden (Netherlands)
Photo of Holger Reithinger, General Partner at Forbion
Holger Reithinger
Forbion·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Munich (Germany)
Photo of Sander Slootweg, Managing Partner at Forbion
Sander Slootweg
Forbion·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Netherlands
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A)
Photo of Marc-Olivier Turgeon, Senior Associate at Forbion
Marc-Olivier Turgeon
Forbion·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Investors in BioTech (Seed), Investors in BioTech (Series A)
Photo of Martien van Osch, Managing Partner at Forbion
Martien van Osch
Forbion·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A)
Photo of Alice Vickers, Advisor at Forbion
Alice Vickers
Forbion·Advisor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom